{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:06:15Z","timestamp":1790445975703,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210572\/Z\/18\/Z"],"award-info":[{"award-number":["210572\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Age-related macular degeneration (AMD) is characterised by a progressive loss of central vision. Intermediate AMD is a risk factor for progression to advanced stages categorised as geographic atrophy (GA) and neovascular AMD. However, rates of progression to advanced stages vary between individuals. Recent advances in imaging and computing technologies have enabled deep phenotyping of intermediate AMD. The aim of this project is to utilise machine learning (ML) and advanced statistical modelling as an innovative approach to discover novel features and accurately quantify markers of pathological retinal ageing that can individualise progression to advanced AMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The PINNACLE study consists of both retrospective and prospective parts. In the retrospective part, more than 400,000 optical coherent tomography (OCT) images collected from four University Teaching Hospitals and the UK Biobank Population Study are being pooled, centrally stored and pre-processed. With this large dataset featuring eyes with AMD at various stages and healthy controls, we aim to identify imaging biomarkers for disease progression for intermediate AMD via supervised and unsupervised ML. The prospective study part will firstly characterise the progression of intermediate AMD in patients followed between one and three years; secondly, it will validate the utility of biomarkers identified in the retrospective cohort as predictors of progression towards late AMD. Patients aged 55\u201390 years old with intermediate AMD in at least one eye will be recruited across multiple sites in UK, Austria and Switzerland for visual function tests, multimodal retinal imaging and genotyping. Imaging will be repeated every four months to identify early focal signs of deterioration on spectral-domain optical coherence tomography (OCT) by human graders. A focal event triggers more frequent follow-up with visual function and imaging tests. The primary outcome is the sensitivity and specificity of the OCT imaging biomarkers. Secondary outcomes include sensitivity and specificity of novel multimodal imaging characteristics at predicting disease progression, ROC curves, time from development of imaging change to development of these endpoints, structure-function correlations, structure-genotype correlation and predictive risk models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is one of the first studies in intermediate AMD to combine both ML, retrospective and prospective AMD patient data with the goal of identifying biomarkers of progression and to report the natural history of progression of intermediate AMD with multimodal retinal imaging.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-022-02097-0","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T06:04:07Z","timestamp":1653458647000},"page":"1275-1283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration\u2014the PINNACLE trial protocol"],"prefix":"10.1038","volume":"37","author":[{"given":"Janice","family":"Sutton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Menten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-0894","authenticated-orcid":false,"given":"Hrvoje","family":"Bogunovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Leingang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1690-9043","authenticated-orcid":false,"given":"Philipp","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3372-7885","authenticated-orcid":false,"given":"Ahmed M.","family":"Hagag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-6279","authenticated-orcid":false,"given":"Sebastian","family":"Waldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1987-8900","authenticated-orcid":false,"given":"Angela J.","family":"Cree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine","family":"Traber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2110-1690","authenticated-orcid":false,"given":"Lars G.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rueckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-7311","authenticated-orcid":false,"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Prevost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5541-4305","authenticated-orcid":false,"given":"Andrew","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"2097_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106\u2013e116.","journal-title":"Lancet Glob Health"},{"key":"2097_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ophtha.2015.09.036","volume":"123","author":"S Schmitz-Valckenberg","year":"2016","unstructured":"Schmitz-Valckenberg S, Sahel JA, Danis R, Fleckenstein M, Jaffe GJ, Wolf S, et al. Natural history of geographic atrophy progression secondary to age-related macular degeneration (Geographic Atrophy Progression Study). Ophthalmology. 2016;123:361\u20138.","journal-title":"Ophthalmology"},{"key":"2097_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ophtha.2006.09.016","volume":"114","author":"JS Sunness","year":"2007","unstructured":"Sunness JS, Margalit E, Srikumaran D, Applegate CA, Tian Y, Perry D, et al. The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology. 2007;114:271\u20137.","journal-title":"Ophthalmology"},{"key":"2097_CR4","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.ophtha.2011.05.008","volume":"118","author":"Z Yehoshua","year":"2011","unstructured":"Yehoshua Z, Wang F, Rosenfeld PJ, Penha FM, Feuer WJ, Gregori G. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology. 2011;118:2434\u201341.","journal-title":"Ophthalmology"},{"key":"2097_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.survophthal.2016.02.005","volume":"61","author":"S Sivaprasad","year":"2016","unstructured":"Sivaprasad S, Bird A, Nitiahpapand R, Nicholson L, Hykin P, Chatziralli I. Perspectives on reticular pseudodrusen in age-related macular degeneration. Surv Ophthalmol. 2016;61:521\u201337.","journal-title":"Surv Ophthalmol"},{"key":"2097_CR6","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.ophtha.2008.04.041","volume":"115","author":"AA Khanifar","year":"2008","unstructured":"Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology. 2008;115:1883\u201390.","journal-title":"Ophthalmology"},{"key":"2097_CR7","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1167\/iovs.18-24106","volume":"59","author":"U Schmidt-Erfurth","year":"2018","unstructured":"Schmidt-Erfurth U, Waldstein SM, Klimscha S, Sadeghipour A, Hu X, Gerendas BS, et al. Prediction of Individual Disease Conversion in Early AMD Using Artificial Intelligence. Investig Ophthalmol Vis Sci. 2018;59:3199\u2013208.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2097_CR8","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1109\/TPAMI.2013.50","volume":"35","author":"Y Bengio","year":"2013","unstructured":"Bengio Y, Courville A, Vincent P. Representation learning: a review and new perspectives. IEEE Trans Pattern Anal Mach Intell. 2013;35:1798\u2013828.","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"2097_CR9","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"Y LeCun","year":"2015","unstructured":"LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436\u201344.","journal-title":"Nature"},{"key":"2097_CR10","doi-asserted-by":"publisher","first-page":"20120072","DOI":"10.1098\/rsfs.2012.0072","volume":"3","author":"K Antila","year":"2013","unstructured":"Antila K, Lotjonen J, Thurfjell L, Laine J, Massimini M, Rueckert D, et al. The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer\u2019s disease. Interface Focus. 2013;3:20120072.","journal-title":"Interface Focus"},{"key":"2097_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000332600","volume":"10","author":"H Soininen","year":"2012","unstructured":"Soininen H, Mattila J, Koikkalainen J, van Gils M, Hviid Simonsen A, Waldemar G, et al. Software tool for improved prediction of Alzheimer\u2019s disease. Neuro-degenerative Dis. 2012;10:149\u201352.","journal-title":"Neuro-degenerative Dis"},{"key":"2097_CR12","first-page":"437","volume":"24","author":"T Schlegl","year":"2015","unstructured":"Schlegl T, Waldstein SM, Vogl WD, Schmidt-Erfurth U, Langs G. Predicting semantic descriptions from medical images with convolutional neural networks. Inf Process Med Imaging. 2015;24:437\u201348.","journal-title":"Inf Process Med Imaging"},{"key":"2097_CR13","first-page":"56","volume":"58","author":"P Seeb\u00f6ck","year":"2017","unstructured":"Seeb\u00f6ck P, Waldstein SM, Donner R, Gerendas BS, Sadeghipour A, Osborne A, et al. Defining disease endophenotypes in neovascular AMD by unsupervised machine learning of large-scale OCT data. Investig Ophthalmol Vis Sci. 2017;58:56\u201356.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2097_CR14","unstructured":"Schlegl T, Seebock P, Waldstein SM, Schmidt-Erfurth U, Langs G. Unsupervised anomaly detection with generative adversarial networks to guide marker discovery. https:\/\/arxiv.org\/abs\/1703.05921."},{"key":"2097_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/tvst.9.2.25","volume":"9","author":"A Bhuiyan","year":"2020","unstructured":"Bhuiyan A, Wong TY, Ting DSW, Govindaiah A, Souied EH, Smith RT. Artificial intelligence to stratify severity of age-related macular degeneration (AMD) and predict risk of progression to late AMD. Transl Vis Sci Technol. 2020;9:25.","journal-title":"Transl Vis Sci Technol"},{"key":"2097_CR16","doi-asserted-by":"crossref","unstructured":"Schmidt-Erfurth U, Waldstein SM, Klimscha S, Sadeghipour A, Hu X, Gerendas BS, et al. Prediction of Individual Disease Conversion in Early AMD Using Artificial Intelligence. Investig Ophthalmol Vis Sci. 2018;59:3199\u2013208.","DOI":"10.1167\/iovs.18-24106"},{"key":"2097_CR17","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1167\/iovs.16-21053","volume":"58","author":"H Bogunovic","year":"2017","unstructured":"Bogunovic H, Waldstein SM, Schlegl T, Langs G, Sadeghipour A, Liu X, et al. Prediction of Anti-VEGF treatment requirements in neovascular AMD using a machine learning approach. Invest Ophthalmol Vis Sci. 2017;58:3240\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2097_CR18","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1016\/j.neuroimage.2010.10.019","volume":"54","author":"M Kuklisova-Murgasova","year":"2011","unstructured":"Kuklisova-Murgasova M, Aljabar P, Srinivasan L, Counsell SJ, Doria V, Serag A, et al. A dynamic 4D probabilistic atlas of the developing brain. Neuroimage. 2011;54:2750\u201363.","journal-title":"Neuroimage"},{"key":"2097_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s42256-020-0154-9","volume":"2","author":"Q Yan","year":"2020","unstructured":"Yan Q, Weeks DE, Xin H, Swaroop A, Chew EY, Huang H, et al. Deep-learning-based prediction of late age-related macular degeneration progression. Nat Mach Intell. 2020;2:141\u201350.","journal-title":"Nat Mach Intell"},{"key":"2097_CR20","first-page":"3398","volume":"58","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth U, Bogunovic H, Klimscha S, Hu X, Schlegl T, Sadeghipour A, et al. Machine learning to predict the individual progression of AMD from imaging biomarkers. Investig Ophthalmol Vis Sci. 2017;58:3398\u20133398.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2097_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.oret.2017.03.015","volume":"2","author":"U Schmidt-Erfurth","year":"2018","unstructured":"Schmidt-Erfurth U, Bogunovic H, Sadeghipour A, Schlegl T, Langs G, Gerendas BS, et al. Machine learning to analyze the prognostic value of current imaging biomarkers in neovascular age-related macular degeneration. Ophthalmol Retin. 2018;2:24\u201330.","journal-title":"Ophthalmol Retin"},{"key":"2097_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology. 2018;125:537\u201348.","journal-title":"Ophthalmology"},{"key":"2097_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69814-1","volume":"10","author":"SM Waldstein","year":"2020","unstructured":"Waldstein SM, Seeb\u00f6ck P, Donner R, Sadeghipour A, Bogunovi\u0107 H, Osborne A, et al. Unbiased identification of novel subclinical imaging biomarkers using unsupervised deep learning. Sci Rep. 2020;10:12954.","journal-title":"Sci Rep"},{"key":"2097_CR24","doi-asserted-by":"crossref","unstructured":"Azizi S. Big self-supervised models advance medical image classification. Proceedings of the IEEE\/CVF International Conference on Computer Vision. Computer Vision Foundation New York, USA, 2021. p. 347\u201388.","DOI":"10.1109\/ICCV48922.2021.00346"},{"key":"2097_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85110-y","volume":"11","author":"W-D Vogl","year":"2021","unstructured":"Vogl W-D, Bogunovi\u0107 H, Waldstein SM, Riedl S, Schmidt-Erfurth U. Spatio-temporal alterations in retinal and choroidal layers in the progression of age-related macular degeneration (AMD) in optical coherence tomography. Sci Rep. 2021;11:5743.","journal-title":"Sci Rep"},{"key":"2097_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1001\/jamaophthalmol.2020.1376","volume":"138","author":"SM Waldstein","year":"2020","unstructured":"Waldstein SM, Vogl WD, Bogunovic H, Sadeghipour A, Riedl S, Schmidt-Erfurth U. Characterization of drusen and hyperreflective foci as biomarkers for disease progression in age-related macular degeneration using artificial intelligence in optical coherence tomography. JAMA Ophthalmol. 2020;138:740\u20137.","journal-title":"JAMA Ophthalmol"},{"key":"2097_CR27","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris 3rd","year":"2013","unstructured":"Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844\u201351.","journal-title":"Ophthalmology"},{"key":"2097_CR28","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.ophtha.2014.06.034","volume":"121","author":"Z Wu","year":"2014","unstructured":"Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, et al. Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology. 2014;121:2415\u201322.","journal-title":"Ophthalmology"},{"key":"2097_CR29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.1153717","volume":"319","author":"JZ Li","year":"2008","unstructured":"Li JZ, Absher DM, Tang H, Southwick AM, Casto AM, Ramachandran S, et al. Worldwide human relationships inferred from genome-wide patterns of variation. Science. 2008;319:1100\u20134.","journal-title":"Science"},{"key":"2097_CR30","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen WM. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26:2867\u201373.","journal-title":"Bioinformatics"},{"key":"2097_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","volume":"590","author":"D Taliun","year":"2021","unstructured":"Taliun D, Harris DN, Kessler MD, Carlson J, Szpiech ZA, Torres R, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program. Nature. 2021;590:290\u20139.","journal-title":"Nature"},{"key":"2097_CR32","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","volume":"48","author":"S McCarthy","year":"2016","unstructured":"McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48:1279\u201383.","journal-title":"Nat Genet"},{"key":"2097_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-33","volume":"13","author":"P Royston","year":"2013","unstructured":"Royston P, Altman DG. External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol. 2013;13:33.","journal-title":"BMC Med Res Methodol"},{"key":"2097_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/sj.bjc.6601907","volume":"91","author":"A Burton","year":"2004","unstructured":"Burton A, Altman DG. Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer. 2004;91:4\u20138.","journal-title":"Br J Cancer"},{"key":"2097_CR35","doi-asserted-by":"publisher","first-page":"Bio141","DOI":"10.1167\/iovs.17-21789","volume":"58","author":"H Bogunovic","year":"2017","unstructured":"Bogunovic H, Montuoro A, Baratsits M, Karantonis MG, Waldstein SM, Schlanitz F, et al. Machine learning of the progression of intermediate age-related macular degeneration based on OCT imaging. Investivg Ophthalmol Vis Sci. 2017;58:Bio141\u2013bio150.","journal-title":"Investivg Ophthalmol Vis Sci"},{"key":"2097_CR36","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","volume":"123","author":"FL Ferris","year":"2005","unstructured":"Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570\u20134.","journal-title":"Arch Ophthalmol"},{"key":"2097_CR37","doi-asserted-by":"publisher","first-page":"b604","DOI":"10.1136\/bmj.b604","volume":"338","author":"P Royston","year":"2009","unstructured":"Royston P, Moons KGM, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604.","journal-title":"BMJ"},{"key":"2097_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/1467-985X.00122","volume":"162","author":"W Sauerbrei","year":"1999","unstructured":"Sauerbrei W, Royston P. Building multivariable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials. J R Stat Soc: Ser A (Stat Soc). 1999;162:71\u201394.","journal-title":"J R Stat Soc: Ser A (Stat Soc)"},{"key":"2097_CR39","doi-asserted-by":"publisher","first-page":"b605","DOI":"10.1136\/bmj.b605","volume":"338","author":"DG Altman","year":"2009","unstructured":"Altman DG, Vergouwe Y, Royston P, Moons KGM. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605.","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.1038\/s41433-022-02131-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02097-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02097-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02097-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T12:09:06Z","timestamp":1681387746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02097-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2097"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02097-0","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"4 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41433-022-02131-1","URL":"https:\/\/doi.org\/10.1038\/s41433-022-02131-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AL is a consultant for Gyroscope Therapeutics Ltd, Eyebio, Complement Therapeutics, Novartis, Allergan, Apellis and Tarsus Pharmaceuticals. DR is a co-founder and shareholder of IXICO Plc. SS has attended advisory board meetings and received research grants and is a consultant for Genentech Inc.\/F. Hoffmann-La Roche Ltd, Allergen, Bayer and Novartis, Oxurion, Ophtea, Optos, Oculis, Apellis, Eyebio, Gyroscope. SW is a consultant to Bayer, Roche, Santen, B\u00f6hringer Ingelheim and Novartis. USE receives grant support from Genentech, Kodiak, Novartis, RetInSight and Roche and is a consultant for Apellis. HB has received research grants from Heidelberg Engineering and Apellis, and speaker fees from Bayer, Roche, and Apellis. HS is a member of the Scientific Advisory Board of: Astellas Pharma Global Development, Inc.\/Astellas Institute for Regenerative Medicine; Boehringer Ingelheim Pharma GmbH & Co; Gyroscope Therapeutics Ltd.; Janssen Research & Development, LLC (Johnson & Johnson); Novartis Pharma AG (CORE); Okuvision GmbH; and Third Rock Ventures, LLC. He is a consultant of Gerson Lehrman Group; Guidepoint Global, LLC; and Tenpoint Therapeutics Limited. HS is a member of the Data Monitoring and Safety Board\/Committee of Belite Bio (CT2019-CTN-04690-1), ReNeuron Group Plc\/Ora Inc. (NCT02464436), F. Hoffmann-La Roche Ltd (VELODROME trial, NCT04657289; DIAGRID trial, NCT05126966) and member of the Steering Committee of Novo Nordisk (FOCUS trial; NCT03811561). He is a co-director of the Institute of Molecular and Clinical Ophthalmology Basel (IOB) which receives funding from the University of Basel, the University Hospital Basel, Novartis, and the government of Basel-Stadt.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}